Vesugen
Vesugen
Description
A vascular bioregulator peptide supporting blood vessel health and circulation. Important for cardiovascular longevity.
Overview
Vesugen (KED) was developed at the St. Petersburg Institute of Bioregulation and Gerontology by Khavinson and colleagues. It is studied for cardiovascular and immune support, with proposed effects on endothelial function and vascular gene regulation.
Mechanism of Action
Synthetic tripeptide (Lys-Glu-Asp / KED) proposed to bind regulatory DNA regions and modulate gene expression in vascular endothelial and immune tissues; classified as a Khavinson short-chain bioregulator.
Benefits
- •Vascular health
- •Blood flow
- •Circulation
- •Cardiovascular support
Reported Side Effects
- •Limited human safety data
- •Possible injection site reactions
Safety Notes
Limited independent clinical validation outside Russian literature. Research use only.
Scientific References
Related Bioregulator Peptides
Livagen
Livagen
A liver bioregulator peptide supporting hepatic tissue regeneration and function. Essential for metabolic and detoxification health.
2 mgChonluten
Chonluten
A respiratory bioregulator peptide supporting bronchial mucosa and lung function. Part of comprehensive respiratory health protocols.
2 mgPancragen
Pancragen
A pancreatic bioregulator peptide supporting pancreatic tissue health and metabolic function. Important for blood sugar regulation.
2 mgVilon
Vilon
A thymus bioregulator peptide with anti-inflammatory properties. Supports immune function and reduces systemic inflammation.
2 mg